期刊文献+

手术对喉鳞状细胞癌血清中抗survivin抗体表达的影响及其与p53和c-myc自身抗体联合检测的意义 被引量:2

Effects of surgery on expressions of serum anti-survivin antibody and significance of combined detection of anti-survivin,anti-p53 and anti-c-myc antibody in laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的:了解喉鳞状细胞癌(Laryngeal squamous cell carcinoma,LSCC)患者手术前后血清中抗survivin抗体的变化,并分析抗survivin抗体、抗p53抗体和抗c-myc抗体联合检测在LSCC术后监测中的作用。方法:酶联免疫吸附试验(Enzyme-linked immunosorbent assay,ELISA)用于检测血清样本中抗survivin抗体、抗p53抗体和抗c-myc抗体的表达。结果:(1)在接受根治性手术治疗后,抗survivin抗体、抗p53抗体和抗c-myc抗体的表达水平显著下降。(2)抗survivin抗体在LSCC患者外周血清中高表达,特别是有颈淋巴结转移的样本。(3)抗survivin抗体、抗p53抗体和抗c-myc抗体单独检测时均获得了较高的阳性率;3种抗体联合检测的阳性率并不优于抗survivin抗体的阳性率,但优于抗p53抗体和抗c-myc抗体。结论:抗survivin抗体可能是LSCC的一种有价值的生物标记物。抗survivin抗体、抗p53抗体和抗c-myc抗体联合检测在手术治疗效果监测方面有积极意义。 Objective: To exam the serum anti-survivin antibody levels in post-surgery and pre-surgery samples of patients with laryngeal squamous cell carcinoma(LSCC) and to investigate the potential use of anti-survivin,anti-p53,and anti-c-myc antibodies in the monitoring of LSCC postoperatively. Methods:Enzyme-linked immunosorbent assay (ELISA) was used for the detection of serum anti-survivin, anti-p53, and anti-c-myc antibodies. Results: (1)After radical surgical treatment,the anti-survivin, anti-p53, and anti-c-myc antibodies expression levels were decreased significantly. (2)High levels of anti-survivin antibody were detected in the serum sample of patients with LSCC,especially in samples from individuals with cervical lymphatic metastasis. (3)High positive detection rates were obtained through independent testing of anti-survivin, anti-p53 and anti-c-myc antibodies;the combined positive rate of all three antibodies was inferior to that of anti-survivin antibody but superior to that of anti-p53 and anti-c-myc antibodies. Conclusions:This indicates that anti-survivin antibody may be a biomarker of LSCC. Combined testing of three different tumor markers may be valuable for monitoring of the surgery efficacy.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2012年第8期673-677,共5页 Journal of Chongqing Medical University
基金 重庆市卫生局医学科研计划资助项目(编号:2010-2-098)
关键词 喉鳞状细胞癌 凋亡抑制蛋白 抗体 血清 手术 laryngeal squamous cell carcinoma inhibitor of apoptosis protein antibody serum surgery
  • 相关文献

参考文献16

  • 1李连弟,饶克勤,张思维,鲁凤珠,邹小农.中国12市县1993年~1997年肿瘤发病和死亡登记资料统计分析[J].中国肿瘤,2002,11(9):497-507. 被引量:193
  • 2Anderson K S,LaBaer J.The sentinel within:exploiting the immune system for cancer biomarkers [J].J Proteome Res, 2005,4 (4) : 1123 - 1133.
  • 3Dong Y,Sui L,Watanabe Y,et al.Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications[J].Anticaneer Res, 2002,22 ( 4 ) : 2377 -2383.
  • 4Megliorino R,Shi F D,Peng X X,et al.Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection[J].Cancer Detection and Prevention, 2005,29 (3) : 241-248.
  • 5Hoffman W H,Biade S,Zilfou J T,et al.Transcriptional repression of the anti-apoptotic survivin gene by wild type p53[J].J Biol Chem, 2002,277 (5) : 3247-3257.
  • 6宋悦,孔北华,刘培淑,马道新,江森.3种卵巢癌细胞中hTERT转录水平及其与端粒酶活性的相关性研究[J].癌症,2003,22(5):486-491. 被引量:6
  • 7Lo Muzio L,Pannone G,Staibano S,et al.Survivin expression in or- al squamous cell carcinoma[J].Br J Cancer, 2003,89(12) : 2244-2248.
  • 8Lo Muzio L, Farina A, Rubini C, et al.Survivin as prongostic fac- torin squamous cell carcinoma of the oral caviiy[J].Cancer Lett,2005, 225 ( 1 ) : 27-33.
  • 9Yagihashi A,Ohmura T,Asanuma K,et al.Detection of autoantibod- ies to survivin and livin in sera from patients with breast cancer[J].Clin Chim Acta, 2005,362 (1-2) : 125-130.
  • 10Satoh K,Kaneko K,Hirota M,et al.Expression of survivin is corr- elated with cancer cell apoptosis and is involved in the development of humanpancreatic duct cell tumors[J].Cancer, 2001,92(2) : 271-278.

二级参考文献14

  • 1Lichtsteiner SP, Lebkowski JS, Vasserot AP. Telomerase, a target for anticancer therapy[J], Ann NY Acad Sci, 1999, 886:1-11.
  • 2Dome JS, Look AT. Three molecular determinants of malignant conversion and their potential as therapeutic targets[J]. Curr Opin Oncol, 1999, 11:58 -67.
  • 3Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization[J]. Cell, 1997,90(4): 785-795.
  • 4Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells[J]. Science(Wash. DC), 1998,279:349-352.
  • 5Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter[J]. Hum Mol Genet, 1999, 8:137 - 142.
  • 6Kim NM, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer[J].Science(Wash. DC), 1994, 266:2011 - 2015.
  • 7McKenzie KE, Umbricht CB, Sukumar S. Applications of telomerase research in the fight against cancer [ J ]. Mol Med Today, 1999, 5: 114-122.
  • 8Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas[J]. Nat Genet, 1998, 18:65 -68.
  • 9Buick RN, Pullano R, Trent JM. Comparative properties of five human ovarian adenocarcinoma cell lines[J]. Cancer Res,1985, 45:3668 - 3676.
  • 10Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for trascriptional activation in immortalized amt cancer cells [ J ].Cancer Res, 1999, 59:551 - 557.

共引文献197

同被引文献18

  • 1冯振中,陈嘉薇,杨兆瑞,路光中,蔡兆根.PTEN、HIF-1α和NDRG1在子宫内膜样腺癌中的表达和相关性研究[J].上海交通大学学报(医学版),2011,31(2):203-207. 被引量:4
  • 2Matenia D, Hempp C, Timm T, et al. Microtubule affinity-regula- ting Kinase2 ( MARK2 ) turns on phosphatase and tensin homolog (PTEN) -induced Kinase 1 ( PINK1 ) at Thr-313, a mutation sitein parkinson disease: effects on mitochondrial transport [ J ]. J Biol Chem, 2012(11) :8174 -86.
  • 3Walig6rska-Stachura J, Jankowska A, Wagko R, et al. Survivin- prognostic tumor biomarker in human neoplasms-review [ J ]. Ginekol Pol, 2012,83(7) :537 -40.
  • 4Huang J, Yan J, Zhang J, et al. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plas- ma membrane[J]. Nat Commun, 2012,19(3) :911.
  • 5Lu H, Gan M, Zhang G, et aL Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue mieroarray: correla- tion with clinicopathology and prognosis [ J ]. Eur J Gynaecol On- col, 2010,31(6) :662 -6.
  • 6Yagihashi A, Ohmura T, Asanuma K, et al. Detection of autoanti- bodies to survivin and livin in sera from patients with breast cancer [J]. Clin Chim Acta, 2005,362(1 -2) :125 -30.
  • 7Chen J S, Chen K T, Fan W C, et al. Combined analysis of sur- vivin autoantibody and carcinoembryonic antigen biomarkers for im- proved detection of colorectal cancer [ J ]. Clin Chem Lab Med, 2010,48(5) :719 -25.
  • 8武建国.卵巢癌的生物标志物[J].临床检验杂志,2012,30(2):84-88. 被引量:25
  • 9姜秋红,程能能,高惠君.上皮性卵巢癌中P53蛋白的表达与化疗敏感相关性[J].中国新药与临床杂志,2012,31(11):689-692. 被引量:5
  • 10张芬,王志红,赵敏,王华,黄金.良恶性胃溃疡组织中PTEN、survivin的表达及意义[J].临床与实验病理学杂志,2013,29(2):167-170. 被引量:9

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部